Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: Not a Bargaining Chip: Beijing Is Dismantling Nvidia’s China Playbook and more

In today’s briefing:

  • Not a Bargaining Chip: Beijing Is Dismantling Nvidia’s China Playbook
  • What Is the Real Prize in Nvidia’s $5B Intel Bet?
  • The Beat Ideas: Northern Arc Capital – A Niche Player in a Crowded Field?
  • ZIM Integrated’s $20 Buyout Drama—Is A Takeover Inevitable?
  • GE Vernova Stock Explodes 5x Post Spin-Off: What’s Fueling The Surge?
  • Pitney Bowes Inc (PBI) – Thursday, Jun 19, 2025
  • Health & Happiness (H&H 1112HK): After the Pain, Is It Finally Time for Gain?
  • RE Stock Implications from Fed’s Rate Cut and HK PA: Focus on Big Picture, Macro and Sector Drivers
  • NVIDIA In The Crosshairs: China’s Antitrust Crackdown Threatens Billions In AI Chip Revenue!
  • IBM Just Took The Lead In The Quantum Arms Race—And It’s Only The Beginning!


Not a Bargaining Chip: Beijing Is Dismantling Nvidia’s China Playbook

By Raghav Vashisht

  • China’s analog chip probe and revived Nvidia antitrust case are part of a deeper strategy to force foreign tech out of its supply chain.
  • Nvidia’s China-only B40 flops, with buyers preferring grey market alternatives. Meanwhile, Domestic chipmakers like Novosense and SG Micro have rallied sharply as procurement tilts inward.
  • If Beijing blocks Nvidia’s B30A next, it could mark a full commercial exit. U.S. peers like TXN, AMD, and Synopsys may also not be far behind.

What Is the Real Prize in Nvidia’s $5B Intel Bet?

By Raghav Vashisht

  • Nvidia takes a $5B stake in Intel and will co-develop custom x86 CPUs for data centers and RTX-integrated SoCs for PCs.
  • The phrasing of “fusion of two world-class platforms” signals ambitions beyond just product collaboration. 
  • Intel shares surged +30% on the news, while AMD and Arm slumped; toolmakers like ASML and Synopsys rallied on expectations of fresh CapEx.

The Beat Ideas: Northern Arc Capital – A Niche Player in a Crowded Field?

By Nimish Maheshwari

  • Northern Arc is fast shifting toward direct retail Lending (D2C), while leveraging originator partnerships and technology; recent rate cuts and regulatory relief are improving cost of funds & capital efficiency.
  • Northern Arc’s mix of structured finance, co-lending, and fund management creates steady fee income, making it more resilient than traditional NBFCs relying mainly on heavy lending assets.
  • Northern Arc is a differentiated NBFC benefits from inclusion & fintech growth, but valuation relies on retail execution, risk control, and asset quality pressures.

ZIM Integrated’s $20 Buyout Drama—Is A Takeover Inevitable?

By Baptista Research

  • ZIM Integrated Shipping Services reported its second quarter 2025 financial results during a period characterized by severe market disruptions primarily due to tariff changes in the U.S.
  • Despite these challenges, the company leveraged its modernized fleet and improved cost structure to generate revenue of $1.6 billion, a net income of $24 million, and an adjusted EBITDA of $472 million.
  • The adjusted EBITDA margin stood at 29%, while the adjusted EBIT margin came in at 9%.

GE Vernova Stock Explodes 5x Post Spin-Off: What’s Fueling The Surge?

By Baptista Research

  • GE Vernova, a recent spin-off from General Electric, has seen its stock skyrocket nearly 5x since its separation in April 2024.
  • With the company now trading around $628 and an analyst target pushing it to $740, investor enthusiasm is boiling over.
  • The latest catalyst?

Pitney Bowes Inc (PBI) – Thursday, Jun 19, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Pitney Bowes is trading at approximately 5x free cash flow after appointing Kurt Wolf as CEO.
  • The company has transformed from a distressed credit to a cash-generating entity with growth catalysts like increased share repurchases.
  • Despite positive changes, the stock is undervalued with a 20% levered FCF yield, indicating potential for both short-term and long-term growth.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Health & Happiness (H&H 1112HK): After the Pain, Is It Finally Time for Gain?

By Devi Subhakesan

  • After sinking to 10-year lows in January,  Health And Happiness (H&H) ’s stock has rebounded more than 75%, raising the question of whether operations are finally turning the corner.
  • With signs of stabilizing growth and improving returns across product categories, 1H2025 results seem to signal the end of years of investor agony.
  • Nutritional supplements now contribute to 65% of H&H’s revenue – Swisse’s strong positioning in the fast-growing anti-aging category underpins future growth.

RE Stock Implications from Fed’s Rate Cut and HK PA: Focus on Big Picture, Macro and Sector Drivers

By Jacob Cheng

  • The Fed announced a 25bps rate cut, which is largely anticipated by the market.  The SEP median estimate indicates 2 more cuts in 2025
  • Regarding HK policy address, there are no meaningful positive surprise related to the property market.  It highlights the importance of Northern Metropolis development, and improving home ownership, and talent admission
  • Investors should see-through these and focus on big picture: macro developments, monetary policy, and sector fundamentals.  Pick company with attractive valuation and catalysts: NWD, Link REIT, CICT, COLI, VNET, GDS

NVIDIA In The Crosshairs: China’s Antitrust Crackdown Threatens Billions In AI Chip Revenue!

By Baptista Research

  • The geopolitical tech battle between the U.S. and China has taken a sharp turn—and Nvidia is now squarely in the crosshairs.
  • In a significant escalation, China’s State Administration for Market Regulation has launched an antitrust probe against Nvidia, claiming the chipmaker violated monopoly laws during its $7 billion acquisition of Israeli firm Mellanox Technologies.
  • The regulator’s preliminary findings come at a delicate moment as U.S. and Chinese officials wrap up high-stakes trade talks in Madrid.

IBM Just Took The Lead In The Quantum Arms Race—And It’s Only The Beginning!

By Baptista Research

  • The race toward quantum advantage is entering its most critical phase, and IBM has quietly positioned itself as the frontrunner in a highly competitive field dominated by tech giants like Google, Microsoft, and Amazon.
  • In its Q2 2025 earnings call, IBM confirmed a major milestone: the deployment of IBM Quantum System Two in Japan, the first such system outside the United States.
  • This isn’t just a milestone in hardware—it signals IBM’s intent to establish global leadership in quantum computing infrastructure.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars